The DOI matches its Crossref record; 108 of the 118 references it cites were found in a registry or an index.
TP53 mutations in human cancers: origins, consequences, and clinical use.
Open accessAbstract
Somatic mutations in the TP53 gene are one of the most frequent alterations in human cancers, and germline mutations are the underlying cause of Li-Fraumeni syndrome, which predisposes to a wide spectrum of early-onset cancers. Most mutations are single-base substitutions distributed throughout the coding sequence. Their diverse types and positions may inform on the nature of mutagenic mechanisms involved in cancer etiology. TP53 mutations are also potential prognostic and predictive markers, as well as targets for pharmacological intervention. All mutations found in human cancers are compiled in the IARC TP53 Database (http://www-p53.iarc.fr/). A human TP53 knockin mouse model (Hupki mouse) provides an experimental model to study mutagenesis in the context of a human TP53 sequence. Here, we summarize current knowledge on TP53 gene variations observed in human cancers and populations, and current clinical applications derived from this knowledge.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Of note, 38-50% of human cancers carry inactivating alterations in TP53 (ref. 132 ) , 48-80% in CDKN2A 133 and 14% in CIP1 (ref. 134 ) , while 15-20% and up to 8% harbour oncogenic mutations in RAS and BRAF , respectively 135,136 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [132]
Experimental — accuracy not yet measuredIn the citing paper
“Activated p53 regulates expression of a set of anti-proliferative genes (Olivier et al., 2010; Kastenhuber and Lowe, 2017).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Olivier et al., 2010
In the citing paper
“As p53 remains wild type in $50% of human cancers, 6 reactivation of p53 by small molecules is an attractive therapeutic approach.”
From Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53-independent pancreatic cancer cell death (2013) · cites this paper as [6]
In the citing paper
“Tumors, which drastically deviate from these parameters, have evolved multiple mechanisms to inactivate TP53, the most prevalent of which is the emergence of TP53 missense mutations, some of which have gain-of function activities.”
From The Mdm network and its regulation of p53 activities: a rheostat of cancer risk (2014) · cites this paper as Olivier, et al., 2010
In the citing paper
“In particular, missense mutations account for approximately 75% of all TP53 mutations in cancer (Hamroun, et al., 2006; Olivier, et al., 2010)”
From The Mdm network and its regulation of p53 activities: a rheostat of cancer risk (2014) · cites this paper as Olivier, et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Self-citationp53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Instability and decay of the primary structure of DNA
Lindahl, T. (1993) · Nature · doi:10.1038/362709a0 · Cited by 5,679
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,625
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D. L., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,161
Patterns of somatic mutation in human cancer genomes
Greenman, C. D., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G. R., Davies, H. R., Teague, J. W., Butler, A. P., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,143
Somatic mutations affect key pathways in lung adenocarcinoma
Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B., et al. (2008) · Nature · doi:10.1038/nature07423 · Cited by 2,681
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,559 · cited 2×
“The p53 DBD is made of an immunoglobulinlike b-sandwich of two antiparallel b-sheets, providing a scaffold for a flexible DNA-binding surface (Cho et al. 1994).”
Background
Flagged first, then by citations
10 of the 118 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 701–800 of 1,002
Azathioprine antagonizes aberrantly elevated lipid metabolism and induces apoptosis in glioblastoma
Nam, H. J., Kim, Y. E., Moon, B.-S., Kim, H. Y., Jung, D., Choi, S., Jang, J. W., Nam, D., & Cho, H. (2021) · iScience · doi:10.1016/j.isci.2021.102238 · Cited by 24
p53 mRNA Metabolism Links with the DNA Damage Response
Gnanasundram, S. V., Bonczek, O., Wang, L., Chen, S., & Fåhræus, R. (2021) · Genes · doi:10.3390/genes12091446 · Cited by 27
Dashti, H., Dehzangi, A., Bayati, M., Breen, J., Lovell, N., Ebrahimi, D., Rabiee, H. R., & Alinejad‐Rokny, H. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04652-8 · Cited by 25
Genotype Versus Phenotype: The Yin and Yang of Germline TP53 Mutations in Li-Fraumeni Syndrome
Nichols, K. E., & Malkin, D. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.5757 · Cited by 27
Molecular Mechanism of Resveratrol and Its Therapeutic Potential on Female Infertility
Podgrajšek, R., Frangež, H. B., & Štimpfel, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073613 · Cited by 22
Exploring the Role of p53 in Radiosensitivity: A Key Player in Cancer Therapy
Al-Arafat, T., Mao, A., Katsube, T., & Wang, B. (2024) · Radiation · doi:10.3390/radiation4040023 · Cited by 23
Single Amino Acid Variant Discovery in Small Numbers of Cells
Tan, Z., Yi, X., Carruthers, N. J., Stemmer, P. M., & Lubman, D. M. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00694 · Cited by 21
Genetic Influences in Breast Cancer Drug Resistance
Daniyal, A., Santoso, I., Gunawan, N. H. P., Barliana, M. I., & Abdulah, R. (2021) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s284453 · Cited by 24
Zając, A. E., Król, S. K., Rutkowski, P. L., & Czarnecka, A. M. (2021) · Cancers · doi:10.3390/cancers13061317 · Cited by 23
Li, J., Wang, J., Su, D., Nie, X., Liu, Y., Teng, L., Pang, J., Wu, H., & Liang, Z. (2021) · Gastroenterology Research and Practice · doi:10.1155/2021/2510195 · Cited by 22
Liao, H., Zhang, J., Zheng, T., Liu, X., Zhong, J., Shao, B., Dong, X., Wang, X., Du, P., King, B. L., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03421-8 · Cited by 23
Searching for the Metabolic Signature of Cancer: A Review from Warburg’s Time to Now
Jacquet, P., & Stéphanou, A. (2022) · Biomolecules · doi:10.3390/biom12101412 · Cited by 22
Zhang, X., Zhang, M., Sun, H., Wang, X., Wang, X., Sheng, W., & Xu, M. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.01.033 · Cited by 22
Inference of gene regulatory networks based on directed graph convolutional networks
Wei, P.-J., Guo, Z., Gao, Z., Ding, Z., Cao, R., Su, Y., & Zheng, C.-H. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae309 · Cited by 22
Ruan, X., Zuo, Q., Jia, H., Chau, J. F. L., Lin, J., Ao, J., Xia, X., Liu, H., Habib, S. L., Fu, C., et al. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv015 · Cited by 22
Nucleotide Excision Repair: From Neurodegeneration to Cancer
Liakos, A., Lavigne, M. D., & Fousteri, M. I. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-60733-7_2 · Cited by 24
Mujib, S. A., Alamsyah, F., & Taruno, W. P. (2017) · Integrative Medicine International · doi:10.1159/000485186 · Cited by 21
TICRR Contributes to Tumorigenesis Through Accelerating DNA Replication in Cancers
Yu, Q., Pu, S.-Y., Wu, H., Chen, X., Jiang, J., Gu, K.-S.-Y., He, Y., & Kong, Q. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00516 · Cited by 22
Mutant p53 as an Antigen in Cancer Immunotherapy
Sobhani, N., D’Angelo, A., Wang, X., Young, K. H., Generali, D., & Li, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114087 · Cited by 23
Autoimmunity, Clonal Hematopoiesis, and Myeloid Neoplasms
Bekele, D. I., & Patnaik, M. M. (2020) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2020.03.001 · Cited by 22
Cancer and Tumour Suppressor p53 Encounters at the Juncture of Sex Disparity
Haupt, S., & Haupt, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.632719 · Cited by 22
TP53 modulates radiotherapy fraction size sensitivity in normal and malignant cells
Anbalagan, S., Ström, C. E., Downs, J. A., Jeggo, P. A., McBay, D., Wilkins, A. C., Rothkamm, K., Harrington, K. J., Yarnold, J. R., & Somaiah, N. (2021) · Scientific Reports · doi:10.1038/s41598-021-86681-6 · Cited by 23
Hao, Q., Long, Y., Yang, Y., Deng, Y., Ding, Z., Yang, L., Shu, Y., & Xu, H. (2024) · Vaccines · doi:10.3390/vaccines12070717 · Cited by 22
Hwang, S. H., Baek, S. H., Lee, M. J., Kook, Y., Bae, S. J., Ahn, S. G., & Jeong, J. (2024) · Cancers · doi:10.3390/cancers16233899 · Cited by 21
SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes
Herbert, K. J., Cook, A. L., & Snow, E. T. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.04.001 · Cited by 21
Fujimoto, A., Okada, Y., Boroevich, K. A., Tsunoda, T., Taniguchi, H., & Nakagawa, H. (2016) · Scientific Reports · doi:10.1038/srep26483 · Cited by 21
Metabolic Constrains Rule Metastasis Progression
Roda, N., Gambino, V., & Giorgio, M. (2020) · Cells · doi:10.3390/cells9092081 · Cited by 22
A review on engineered magnetic nanoparticles in Non-Small-Cell lung carcinoma targeted therapy
Ngema, L. M., Adeyemi, S. A., Marimuthu, T., & Choonara, Y. E. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120870 · Cited by 21
Blum, J. L., Laird, A. D., Litton, J. K., Rugo, H. S., Ettl, J., Hurvitz, S. A., Martin, M., Roche, H. H., Lee, K.-H., Goodwin, A., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2080 · Cited by 21
Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes
Choi, H., & Baek, K. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04132-5 · Cited by 27
Biomarkers for patients with Wilms tumor: a review
Zheng, H., Liu, J., Pan, X., & Cui, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1137346 · Cited by 23
Caspase-2 protects against ferroptotic cell death
Dawar, S., Benitez, M. C., Lim, Y. P., Dite, T. A., Yousef, J. M., Thio, N., Garciaz, S., Jackson, T. D., Milne, J. V., Dagley, L. F., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06560-6 · Cited by 21
Zhang, Z., Wu, C., Liu, N., Wang, Z., Pan, Z., Jiang, Y., Tian, J., & Sun, M. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118277 · Cited by 21
Jansen, J., Bohnsack, K. E., Böhlken-Fascher, S., Bohnsack, M. T., & Dobbelstein, M. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114610 · Cited by 21
P53 at the start of the 21st century: lessons from elephants
Haupt, S., & Haupt, Y. (2017) · F1000Research · doi:10.12688/f1000research.12682.1 · Cited by 20
What is the potential of p53 isoforms as a predictive biomarker in the treatment of cancer?
Hayman, L., Chaudhry, W. R., Ревин, В. В., Zhelev, N., & Bourdon, J. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1563484 · Cited by 21
Lian, B., Hu, X., & Shao, Z. (2019) · Scientific Reports · doi:10.1038/s41598-019-42184-z · Cited by 21
Tumor Copy Number Deconvolution Integrating Bulk and Single-Cell Sequencing Data
Lei, H., Lyu, B., Gertz, E. M., Schäffer, A. A., Shi, X., Wu, K., Li, G., Xu, L., Hou, Y., Dean, M. C., et al. (2020) · Journal of Computational Biology · doi:10.1089/cmb.2019.0302 · Cited by 20
Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population
Rogoża-Janiszewska, E., Malińska, K., Górski, B., Scott, R. J., Cybulski, C., Kluźniak, W., Lener, M. R., Jakubowska, A., Gronwald, J., Huzarski, T., et al. (2020) · Breast Cancer · doi:10.1007/s12282-020-01151-7 · Cited by 21
An efficient and effective method to identify significantly perturbed subnetworks in cancer
Yang, L., Chen, R., Goodison, S., & Sun, Y. (2021) · Nature Computational Science · doi:10.1038/s43588-020-00009-4 · Cited by 22
p53 Expression as a marker of microinvasion in oral squamous cell carcinoma.
Heah, K. G., Hassan, M. I. A., & Huat, S. C. (2011) · PubMed · Cited by 21
Comparison of Three Different Methods for Determining Cell Proliferation in Breast Cancer Cell Lines
Morten, B. C., Scott, R. J., & Avery‐Kiejda, K. A. (2016) · Journal of Visualized Experiments · doi:10.3791/54350 · Cited by 21
Unraveling the Role of TP53 in Colorectal Cancer Therapy: From Wild-Type Regulation to Mutant
Li, W., Li, L., Yang, H., Shi, C., Lei, Z., Guo, L., & Wang, Y. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2907272 · Cited by 20
Lin, Y., Zhang, Y., Huang, T., Chen, J., Li, G., Zhang, B., Xu, L., Wang, K., He, H., Chen, H., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-1940 · Cited by 23
Oxidative Stress: Noxious but Also Vital
Bagatini, M. D., Jaques, J. A. D. S., de Oliveira, C. S., de Oliveira, G. A., Pillat, M. M., Mânica, A., Moser, C. D. S., dos Santos, L. D., & Ulrich, H. (2018) · InTech eBooks · doi:10.5772/intechopen.73394 · Cited by 19
Zhu, H., Jia, X., Wang, Y., Song, Z., Wang, N., Yang, Y., & Shi, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.714267 · Cited by 20
TP53 in Myelodysplastic Syndromes
Jiang, Y., Gao, S., Soubise, B., Douet‐Guilbert, N., Liu, Z., & Troadec, M. (2021) · Cancers · doi:10.3390/cancers13215392 · Cited by 22
Towards Personalized Nutrition Applications with Nutritional Biomarkers and Machine Learning
Panagoulias, D. P., Sotiropoulos, D. N., & Tsihrintzis, G. A. (2021) · Learning and analytics in intelligent systems · doi:10.1007/978-3-030-87132-1_5 · Cited by 20
Botrus, G., Usón, P. L. S., Raman, P., Kaufman, A. E., Kosiorek, H., Yin, J., Fu, Y., Majeed, U., Sonbol, M. B., Ahn, D. H., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.794009 · Cited by 20
Hinokiflavone Inhibits MDM2 Activity by Targeting the MDM2-MDMX RING Domain
Ilic, V. K., Egorova, O., Tsang, E., Gatto, M., Wen, Y., Zhao, Y., & Sheng, Y. (2022) · Biomolecules · doi:10.3390/biom12050643 · Cited by 20
Wang, S., Cui, J., Fan, Q., Gan, J., Liu, C., Wang, Y., Yang, T., Wang, J., & Yang, C. J. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c01743 · Cited by 20
Liu, Z., Guo, L., Yan, Z., Li, L., Wu, X., Shi, J., He, J., Zhao, L., Liang, H., & Wang, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.989275 · Cited by 20
Alterations in the p53 isoform ratio govern breast cancer cell fate in response to DNA damage
Reinhardt, L. S., Zhang, X., Groen, K., Morten, B. C., Iuliis, G. N. D., Braithwaite, A. W., Bourdon, J., & Avery‐Kiejda, K. A. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05349-9 · Cited by 20
Decraene, B., Vanmechelen, M., Clément, P. M., Daisne, J., Bempt, I. V., Sciot, R., Garg, A. D., Agostinis, P., Smet, F. D., & Vleeschouwer, S. D. (2023) · Cancer Medicine · doi:10.1002/cam4.5681 · Cited by 18
TP53 in AML and MDS: The new (old) kid on the block
Marks, J. A., Wang, X., Fenu, E. M., Bagg, A., & Lai, C. (2023) · Blood Reviews · doi:10.1016/j.blre.2023.101055 · Cited by 20
H3G34-Mutant Gliomas—A Review of Molecular Pathogenesis and Therapeutic Options
Nguyen, A. V. P., Soto, J. M., Gonzalez, S.-M. C., Murillo, J., Trumble, E. R., Shan, F. Y., & Huang, J. H. (2023) · Biomedicines · doi:10.3390/biomedicines11072002 · Cited by 22
Sengupta, S., Singh, N., Paul, A., Datta, D., Chatterjee, D., Mukherjee, S., Gadhe, L. G., Devi, J., Yeshwant, M., Jolly, M. K., et al. (2023) · Journal of Cell Science · doi:10.1242/jcs.261017 · Cited by 20
Computational approach for deriving cancer progression roadmaps from static sample data
Sun, Y., Yao, J. B., Yang, L., Chen, R., Nowak, N. J., & Goodison, S. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx003 · Cited by 18
Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers
Zhang, W., Edwards, A., Flemington, E. K., & Zhang, K. (2017) · Cancer Informatics · doi:10.1177/1176935117691267 · Cited by 20
Wilde, S., Dambowsky, M., Hempt, C., Sutter, A. P., & Queisser, N. (2017) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22130 · Cited by 20
Alaee, M., Nool, K., & Pasdar, M. (2018) · Cancer Science · doi:10.1111/cas.13612 · Cited by 19
Miyazaki, M., Otomo, R., Matsushima‐Hibiya, Y., Suzuki, H., Nakajima, A., Abe, N., Tomiyama, A., Ichimura, K., Matsuda, K., Watanabe, T., et al. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0059-0 · Cited by 20
Shin, Y.-J., Kim, Y.-H., Wen, X., Cho, N., Lee, S., Kim, W. H., & Kang, G. H. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0661-x · Cited by 20
Olivier, M., Bouaoun, L., Villar, S., Robitaille, A., Cahais, V., Heguy, A., Byrnes, G. B., Calvez‐Kelm, F. L., Torres-Mejı́a, G., Alvarado‐Cabrero, I., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210372 · Cited by 21
Self-citationSex- and Mutation-Specific p53 Gain-of-Function Activity in Gliomagenesis
Rockwell, N., Yang, W., Warrington, N. M., Staller, M. V., Griffith, M., Griffith, O. L., Gurnett, C. A., Cohen, B. A., Baldridge, D., & Rubin, J. B. (2021) · Cancer Research Communications · doi:10.1158/2767-9764.crc-21-0026 · Cited by 23
The Mutational and Microenvironmental Landscape of Cutaneous Squamous Cell Carcinoma: A Review
Hosseini, T. M., Park, S. J., & Guo, T. W. (2024) · Cancers · doi:10.3390/cancers16162904 · Cited by 24
Liao, X., Han, C., Qin, W., Liu, X., Yu, L., Zhu, G., Yu, T., Lu, S., Su, H., Liu, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16346 · Cited by 19
Tomasello, B., Mauro, M. D. D., Malfa, G. A., Acquaviva, R., Sinatra, F., Spampinato, G., Laudani, S., Villaggio, G., Bielak-Żmijewska, A., Grabowska, W., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155328 · Cited by 19
Vitto, H. D., Ryu, J., Calderón-Aparicio, A., Monts, J., Dey, R., Chakraborty, A., Lee, M., Bode, A. M., & Dong, Z. (2020) · Cancer & Metabolism · doi:10.1186/s40170-020-00234-5 · Cited by 19
Bohl, S., Schmalbrock, L. K., Bauhuf, I., Meyer, T., Dolnik, A., Szyska, M., Blätte, T. J., Knödler, S., Röhner, L., Miller, D., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003541 · Cited by 19
Pal, P., Starkweather, K. N., Hales, K. H., & Hales, D. B. (2021) · Comparative Medicine · doi:10.30802/aalas-cm-20-000116 · Cited by 19
MicroRNA Function Can Be Reversed by Altering Target Gene Expression Levels
Svoronos, A. A., Campbell, S. G., & Engelman, D. M. (2021) · iScience · doi:10.1016/j.isci.2021.103208 · Cited by 19
LYRUS: a machine learning model for predicting the pathogenicity of missense variants
Lai, J., Yang, J., Uzun, E. D. G., Rubenstein, B. M., & Sarkar, I. N. (2021) · Bioinformatics Advances · doi:10.1093/bioadv/vbab045 · Cited by 18
Dhakar, R., Dakal, T. C., & Sharma, A. (2022) · Genomics · doi:10.1016/j.ygeno.2022.110401 · Cited by 19
Zhang, Y., Jiang, H., Wang, Z., Zhai, B., & Lin, M. (2022) · Oncology Letters · doi:10.3892/ol.2022.13589 · Cited by 19
RIG-I immunotherapy overcomes radioresistance in p53-positive malignant melanoma
Lambing, S., Tan, Y. P., Vasileiadou, P., Holdenrieder, S., Müller, P., Hagen, C., Garbe, S., Behrendt, R., Schlee, M., van den Boorn, J. G., et al. (2023) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjad001 · Cited by 22
Fan, X., Zhong, Y., Yuan, F., Zhang, L., Cai, Y., & Liao, L. (2023) · Scientific Reports · doi:10.1038/s41598-023-27676-3 · Cited by 19
Pereira, M. P., Herrity, E., & Kim, D. D. H. (2023) · Annals of Hematology · doi:10.1007/s00277-023-05462-5 · Cited by 20
Role of MTA1 in head and neck cancers
Marzook, H., Sankaran, D., Kumar, R., & Pillai, M. R. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9521-5 · Cited by 19
Aydın, S., Dekairelle, A., Ambroise, J., Durant, J.-F., Heusterspreute, M., Guiot, Y., Cosyns, J., & Gala, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106301 · Cited by 19
Borges, L. M., & Ayres, F. M. (2015) · Genetics and Molecular Research · doi:10.4238/2015.december.16.4 · Cited by 19
Control of Nucleotide Metabolism Enables Mutant p53’s Oncogenic Gain-of-Function Activity
Schmidt, V. A., Nagar, R., & Martinez, L. A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122759 · Cited by 20
Yamaguchi, S., Takahashi, S. I., Mogushi, K., Izumi, Y., Nozaki, Y., Nomizu, T., Kakugawa, Y., Ishida, T., Ohuchi, N., Ishioka, C., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24447 · Cited by 19
Reverse strand-displacement amplification strategy for rapid detection of p53 gene
Wang, L., Han, Y., Xiao, S., Lv, S., Wang, C., Zhang, N., Wang, Z., Tang, Y., Li, H., Lyu, J., et al. (2018) · Talanta · doi:10.1016/j.talanta.2018.05.035 · Cited by 19
Petrusca, D. N., Toscani, D., Wang, F., Park, C., Crean, C., Anderson, J. L., Marino, S., Mohammad, K. S., Zhou, D., Silbermann, R. W., et al. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0666-5 · Cited by 19
Single-Nucleotide Polymorphism of the MLX Gene Is Associated With Takayasu Arteritis
Tamura, N., Maejima, Y., Matsumura, T., Vega, R. B., Amiya, E., Ito, Y., Shiheido‐Watanabe, Y., Ashikaga, T., Komuro, I., Kelly, D. P., et al. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.002296 · Cited by 19
Mularski, J., Malarz, K., Pacholczyk, M., & Musioł, R. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.12.012 · Cited by 21
Jarhelle, E., Stensland, H. M. F. R., Hansen, G. Å. M., Skarsfjord, S. H., Jonsrud, C., Ingebrigtsen, M., Strømsvik, N., & Ghelue, M. V. (2019) · Scientific Reports · doi:10.1038/s41598-019-55515-x · Cited by 19
Huang, M., Jin, J., Zhang, F., Wu, Y., Xu, C., Ying, L., & Su, D. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.142 · Cited by 18
Coquerelle, S., Darlington, M., Michel, M., Durand, M., Borget, I., Baffert, S., Marino, P., Lionel Perrier, A., & Durand‐Zaleski, I. (2020) · Value in Health · doi:10.1016/j.jval.2020.03.005 · Cited by 19
New experimental data linking secondhand smoke exposure to lung cancer in nonsmokers
Kim, S., Yoon, J., Tommasi, S., & Nia, A. B. (2012) · The FASEB Journal · doi:10.1096/fj.11-199984 · Cited by 19
Rare missense mutations in RECQL and POLG associate with inherited predisposition to breast cancer
Tervasmäki, A., Mantere, T., Hartikainen, J. M., Kauppila, S., Lee, H., Koivuluoma, S., Grip, M., Karihtala, P., Jukkola‐Vuorinen, A., Mannermaa, A., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31259 · Cited by 20
Functions of genes related to testicular germ cell tumour development
Das, M. K., Kleppa, L., & Haugen, T. B. (2019) · Andrology · doi:10.1111/andr.12663 · Cited by 18
The Evolution of Tumors in Mice and Humans with Germline p53 MutationsPreprint
Levine, A. J., Chan, C. S., Dudgeon, C., Puzio‐Kuter, A. M., & Hainaut, P. L. (2015) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2015.80.027631 · Cited by 19
Self-citationPredicting Mutation-Disease Associations Through Protein Interactions Via Deep Learning
Li, X., Cao, B., Wang, J., Meng, X., Wang, S., Huang, Y., Petretto, E. G., & Song, T. (2025) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2025.3541848 · Cited by 18
Akhavan‐Sigari, R., Baf, M. M. F., Ariabod, V., Rohde, V., & Rahighi, S. (2014) · Rare Tumors · doi:10.4081/rt.2014.5350 · Cited by 18
Polymorphisms in apoptosis-related genes in cutaneous melanoma prognosis: sex disparity
de Oliveira, C., Lourenço, G. J., Rinck‐Junior, J. A., de Moraes, A. M., & Lima, C. S. P. (2017) · Medical Oncology · doi:10.1007/s12032-016-0868-z · Cited by 18
Role of cell-free DNA in haematological malignancies
Lim, J. K., Kuss, B. J., & Talaulikar, D. (2021) · Pathology · doi:10.1016/j.pathol.2021.01.004 · Cited by 18
Intra-vaginal gemcitabine-hybrid nanoparticles for effective cervical cancer treatment
Elhabak, M. A., Ibrahim, S., & Ibrahim, R. R. (2022) · OpenNano · doi:10.1016/j.onano.2022.100090 · Cited by 18
Ma, Y., Pan, H., Liu, Y., Zhang, Y., Hong, S., Huang, J., Weng, S., Yang, Y., Fang, W., Huang, Y., et al. (2022) · Journal of Thoracic Disease · doi:10.21037/jtd-22-1606 · Cited by 21
Metadata
- Authors
- Olivier, M., Hollstein, M., & Hainaut, P.
- Affiliations
- Centre international de recherche sur le cancer (FR)
- University of Leeds (GB)
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2009-11-11
- Volume
- 2
- Issue
- 1
- Pages
- a001008-a001008
- ISSN
- 1943-0264 (ISSN-L)
- PMC
- PMC2827900
- OpenAlex
- W2129769331
- Cited by
- 2,199
- References
- 118
- Citations by year
- 2026: 136 · 2025: 174 · 2024: 233 · 2023: 229 · 2022: 222 · 2021: 178 · 2020: 174 · 2019: 112 · 2018: 139 · 2017: 131 · 2016: 101 · 2015: 97 · 2014: 88 · 2013: 61 · 2012: 72
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- TP53 mutation, somatic mutations, germline TP53 mutation, Li-Fraumeni syndrome, cancer susceptibility, mutagenesis mechanism, prognostic factors, predictive biomarkers, therapeutic target, cancer etiology
- MeSH terms
- Animals, Carcinogens, Humans, Mice, Transgenic, Models, Biological, Mutation, Neoplasms, Prognosis, Gene Expression Regulation, Neoplastic, Genes, p53, Mutagenesis, CpG Islands, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
